Format

Send to

Choose Destination
J Heart Lung Transplant. 2015 Mar;34(3):457-67. doi: 10.1016/j.healun.2014.07.005. Epub 2014 Jul 16.

Pulmonary microvascular lesions regress in reperfused chronic thromboembolic pulmonary hypertension.

Author information

1
Laboratoire de Recherche Chirurgicale, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson.
2
INSERM U999, Labex LERMIT, Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson.
3
Laboratoire de Recherche Chirurgicale, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson; INSERM U999, Labex LERMIT, Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson; Service d'Anatomopathologie, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson; Faculté de Médecine, Université Paris-Sud, Le Kremlin-Bicêtre, France.
4
Laboratoire de Recherche Chirurgicale, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson; INSERM U999, Labex LERMIT, Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson.
5
Service de Chirurgie Thoracique, Vasculaire et de Transplantation Cardiopulmonaire, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson.
6
INSERM U999, Labex LERMIT, Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson; Faculté de Médecine, Université Paris-Sud, Le Kremlin-Bicêtre, France; Service de Pneumologie et Réanimation Respiratoire, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
7
Laboratoire de Recherche Chirurgicale, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson; INSERM U999, Labex LERMIT, Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson; Faculté de Médecine, Université Paris-Sud, Le Kremlin-Bicêtre, France; Service de Chirurgie Thoracique, Vasculaire et de Transplantation Cardiopulmonaire, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson.
8
Laboratoire de Recherche Chirurgicale, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson; INSERM U999, Labex LERMIT, Hypertension Artérielle Pulmonaire: Physiopathologie et Innovation Thérapeutique, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson; Faculté de Médecine, Université Paris-Sud, Le Kremlin-Bicêtre, France; Service de Chirurgie Thoracique, Vasculaire et de Transplantation Cardiopulmonaire, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson. Electronic address: o.mercier@ccml.fr.

Abstract

BACKGROUND:

Pulmonary microvascular disease (PMD) develops in both occluded and non-occluded territories in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and may cause persistent pulmonary hypertension after pulmonary endarterectomy. Endothelin-1 (ET-1) and interleukin-6 (IL-6) are potential PMD severity biomarkers, but it remains unknown whether they are related to occluded or non-occluded territories. We assessed PMD and ET-1/IL-6 gene expression profiles in occluded and non-occluded territories with and without chronic lung reperfusion in an animal CTEPH model.

METHODS:

Chronic PH was induced in 10 piglets by left pulmonary artery (PA) ligation followed by weekly embolization of right lower lobe arteries with enbucrilate tissue adhesive for 5 weeks. At Week 6, 5 of 10 animals underwent left PA reperfusion. At Week 12, animals with and without reperfusion were compared with sham animals (n = 5). Hemodynamics, lung morphometry and ET-1/IL-6 gene expression profiles were assessed in the left lung (LL, occluded territories) and right upper lobe (RUL, non-occluded territories).

RESULTS:

At Week 12, mean PA pressure remained elevated without reperfusion (29.0 ± 2.8 vs 27.0 ± 1.1 mm Hg, p = 0.502), but decreased after reperfusion (30.0 ± 1.5 vs 20.5 ± 1.7 mm Hg, p = 0.013). Distal media thickness in the LL and RUL PAs and systemic vasculature to the LL were significantly lower in the reperfused and sham groups compared with the non-reperfused group. PMD progression was related to ET-1 and IL-6 gene expression in the RUL and to the ET-A/ET-B gene expression ratio in the LL.

CONCLUSIONS:

PMD regressed in occluded and non-occluded territories after lung reperfusion. Changes in ET-1 and IL-6 gene expression were associated with PMD in non-occluded territories.

KEYWORDS:

chronic thromboembolic pulmonary hypertension; endothelin-1; interleukin-6; microvascular disease; pulmonary endarterectomy; pulmonary hypertension

PMID:
25123056
DOI:
10.1016/j.healun.2014.07.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center